It should also be noted that mutated FLT3-ITD responds to the FLT3 ligand, and that leukemia cells express the FLT3 ligand; this has important implications when considering conditions that may increase the FLT3 ligand, such as the post-chemotherapy plasma milieu [14]. The gene discussed is FLT3; the disease is leukemia.